Elite Diosmin Complex
Natural health product licensed in Canada
- Other names
- Riosmin Complex
- Licence holder
- Elitemed Inc.
- NPN or DIN-HM
- 80086123
- Status
- Active licence
- Licence date
- 12 June 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 5-Hydroxy-2-(3-hydroxy-4-méthoxyphényl)-7-(O6-alpha-L-rhamnopyranosyl-bêta-D-glucopyranosyloxy)chromen-4-one Source : Bioflavonoïdes d'agrumes | 600 milligramme | Not calculated |
Non-medicinal ingredients
Eau purifiée, Cellulose microcristalline, Stéarate de magnésium, Fécule de pomme de terre, Povidone
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 day |
Uses authorised in Canada
Relieves signs and symptoms of chronic venous insufficiency/varicose veins, such as pain, swelling, burning sensation, heaviness of the legs, and spider veins. Helps reduce symptoms of heavy leg syndrome such as pain, leg heaviness, sensation of swelling, cramps and edema. Helps to reduce the duration and severity of haemorrhoids. Relieves the symptoms associated with haemorrhoids such as pain, edema. and bleeding.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner if condition worsens. Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking any prescription medications. If symptoms persist or worsen, consult a healthcare practitioner. If you suffer, or experience, inflammation of the skin, thrombophlebitis or subcutaneous induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency or disorder, consult a health care practitioner prior to use. Hypersensitivity/allergy, gastrointestinal discomfort, dizziness, headaches, malaise, and skin reactions have been known to occur, in which case, discontinue use and consult a healthcare practitioner.
Source
Official Health Canada record, licence 80086123
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.